Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CRL 1005

Known as: CRL-1005 
A nonionic block copolymer adjuvant used to enhance viral or non-viral polynucleotide delivery in gene therapy vaccines.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
ABSTRACT FALVAC-1A is a second-generation multitarget, multiepitope synthetic candidate vaccine against Plasmodium falciparum… Expand
Review
2005
Review
2005
The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • figure I
Highly Cited
2000
Highly Cited
2000
A year ago we described a comparison of 19 immunological adjuvants for their ability to augment antibody and T-cell responses… Expand
Highly Cited
1999
Highly Cited
1999
  • F. Wang, E. Bade, +5 authors J. Weber
  • Clinical cancer research : an official journal of…
  • 1999
  • Corpus ID: 12148949
Twenty-five patients with high-risk resected stages IIB, III, and IV melanoma were immunized with a vaccine consisting of the… Expand
  • table 1
  • table 3
  • table 2
  • table 4
  • figure 1
1998
1998
The current influenza virus vaccines induce systemic humoral immunity and short lived cellular immunity in young adults… Expand
1997
1997
The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal… Expand